Skip to main content
Caplight Logo









Versameb AG

Versameb AG

Private
BaselHealthcare & Life Scienceshttps://versameb.com/

Last Round

VC Round

Jul 10, 2023

Total Funding Raised

$18.18M

Company Overview

Versameb AG is a biotechnology company that discovers and develops innovative RNA-based therapeutics for the modulation of protein expression and cellular targeting.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

mRNA therapeuticsRNA medicineRNA therapeuticsbiotechnologydrug discoverymRNA platformclinical-stage biotechtherapeutic targetsbiopharmaprotein expressiontissue regenerationRNA drug designprecision medicinebiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Versameb AG Comparables

Compare Versameb AG with similar companies based on industry and business-model similarity.

Versameb AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Replicate Bioscience
82%
Eli Lilly and Company
81%
Strand Therapeutics
78%

Versameb AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 10, 2023
SeedJul 15, 2020
SeedOct 17, 2019
SeedDec 18, 2018
GrantSep 18, 2017

Key People

Founding team and executive leadership

Klaas Zuideveld

Chief Executive Officer

Executive Team

Versameb AG Investors

Notable investors and investment history

Versameb AG investors
InvestorRounds
BaseLaunchGrant, VC Round, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 15, 2020

    $6.37M raised in Seed round.

  • Dec 18, 2018

    $5.3M round led by BaseLaunch

Versameb AG Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Versameb AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Versameb AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersBasel
Employee Range3
Year Founded2017
Last FundingJul 10, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?